Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

TAL Education Group (NYSE:TAL) shares are trading higher in premarket Thursday after the third-quarter earnings result. The company reported third-quarter FY25 sales growth of 62.4% year-on-year ...

As for pharma sales, JNJ's multiple myeloma therapy Darzalex and antipsychotic Invega Sustenna topped forecasts bringing $3.1B and $1.1B in sales with ~21% YoY and ~5% YoY growth, respectively ...

Topics : Glenmark Pharmaceuticals Glenmark Life Sciences United States pharmaceutical firms ...

ACG, a supplier of integrated solutions for the pharmaceutical and nutraceutical industries, has appointed Jochen Scheil as the new Head of Global Sales for ACG Packaging Materials. Scheil brings over ...

Brokerage firm Investec has initiated a FAST (a high conviction short-term analyst idea) on drug manufacturer Aurobindo Pharma Ltd. with a price target ... Upcoming PenG ramp-up Normalising Eugia ...

Sun Pharma announced a 28% year-on-year growth in its consolidated net profit to ₹3,040 crore for the September quarter, driven by strong sales in various markets, including India and the US.

A leading manufacturer of active pharmaceutical ingredients (APIs), intermediates and formulations, Bajaj Healthcare, in an exchange filing, said the company has received exclusive rights for ...

Eli Lilly (LLY) announced disappointing preliminary sales numbers, lowering its investor guidance for Q4. Meanwhile, Pfizer announced that a study evaluating a bladder cancer drug met a critical ...

Our expert buyer’s guide content examines and highlights what procurement teams should look for in leading sales enablement solutions, prospecting, and automation providers for the pharmaceutical ...